{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Fajardo",
      "state": "PR",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "67162",
      "recalling_firm": "Deseo Rebajar",
      "address_1": "G12 Calle Principal",
      "address_2": "Baralt Ste #3",
      "postal_code": "00738-3774",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Puerto Rico only",
      "recall_number": "D-1351-2014",
      "product_description": "Burn 7 Capsules, supplied in 30 capsules bottle",
      "product_quantity": "120 bottles",
      "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Undeclared sibutramine and phenolphthalein  in Burn 7 dietary supplement",
      "recall_initiation_date": "20131223",
      "center_classification_date": "20140527",
      "termination_date": "20170503",
      "report_date": "20140604",
      "code_info": "MFD: 07.18.2013,  EXP: 07.17.2015",
      "more_code_info": ""
    }
  ]
}